25.11.2010
- Genzyme Corp has met the first in a series of deadlines imposed by U.S. regulators for fixing problems at its Boston plant, a milestone that could bolster the biotech company's...
22.11.2010
- U.S. biotechnology firm Genzyme, which is fending off an $18.5 billion hostile takeover bid from France's Sanofi-Aventis, is considering a new deal structure that Sanofi has said...
18.11.2010
- U.S. biotechnology company Genzyme will sell its diagnostics business to Japan's Sekisui Chemical for $265 million, one of three units it designated for sale in a bid to shore up...
10.11.2010
- French drugmaker Sanofi-Aventis said it has called on bid target Genzyme not to use defensive tactics to block a takeover of the U.S. biotech but to let shareholders decide on its...
29.10.2010
- Sanofi-Aventis expanded its consumer health business in China with a $520.6 million takeover, showing it remains in the market for smaller bolt-on deals as it tries to buy U.S...
20.10.2010
- France's Sanofi Aventis said on Wednesday that it had received the green light from U.S. antitrust regulators to take-over the U.S. biotech Genzyme. Sanofi said that the waiting...
18.10.2010
- Sanofi-Aventis' position remains unchanged regarding a $18.5 billion hostile offer for Genzyme, Sanofi Chief Executive Chris Viehbacher told Reuters on the sidelines of the Women's...
11.10.2010
- Sanofi-Aventis denied that it had dangled a higher price for Genzyme before going hostile with its $18.5 billion bid, deepening the animosity in their transatlantic takeover fight...
